Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple sclerosis, Medicine, Cognition, Physical medicine and rehabilitation, Intensive care medicine, and Natalizumab.
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
Recommendations for cognitive screening and management in multiple sclerosis care
Effectiveness of alternative dose fingolimod for multiple sclerosis